LIAS and breast carcinoma: LIAS mutations impairs mitochondrial energy metabolism [25] Moreover, high LIAS expression has been documented to be related to a favorable prognosis in patients with KIRC, rectal adenocarcinoma (READ), breast carcinoma, and ovarian carcinoma [26].